Aquilo Capital Management, LLC Cytom X Therapeutics, Inc. Transaction History

Aquilo Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $951,521 - $1.16 Million	-101,767 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$9.5 - $19.16 $4.02 Million - $8.1 Million	-422,996 Reduced 80.61%	101,767 $1.09 Million
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $1.9 Million - $2.79 Million	-150,000 Reduced 22.23%	524,763 $7.92 Million
Q3 2018 Nov 14, 2018	BUY	$18.04 - $26.41 $451,000 - $660,250	25,000 Added 3.85%	674,763 $12.5 Million
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $13.9 Million - $19.3 Million	649,763 New	649,763 $14.9 Million

50.2M

22.3K

22.9K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $75.8M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aquilo Capital Management, LLC with notifications on news.